The Cellular Prion Protein and the Hallmarks of Cancer - Sorbonne Université
Journal Articles Cancers Year : 2021

The Cellular Prion Protein and the Hallmarks of Cancer

Sophie Mouillet-Richard
  • Function : Author
  • PersonId : 969762
Alexandre Ghazi
Pierre Laurent-Puig
  • Function : Author
  • PersonId : 946934

Abstract

Beyond its causal involvement in a group of neurodegenerative diseases known as Transmissible Spongiform Encephalopathies, the cellular prion protein PrPC is now taking centre stage as an important contributor to cancer progression in various types of solid tumours. The prion cancer research field has progressively expanded in the last few years and has yielded consistent evidence for an involvement of PrPC in cancer cell proliferation, migration and invasion, therapeutic resistance and cancer stem cell properties. Most recent data have uncovered new facets of the biology of PrPC in cancer, ranging from its control on enzymes involved in immune tolerance to its radio-protective activity, by way of promoting angiogenesis. In the present review, we aim to summarise the body of literature dedicated to the study of PrPC in relation to cancer from the perspective of the hallmarks of cancer, the reference framework defined by Hanahan and Weinberg.

Domains

Cancer
Fichier principal
Vignette du fichier
cancers-13-05032-v2.pdf (2.2 Mo) Télécharger le fichier
Origin Publication funded by an institution

Dates and versions

hal-03379898 , version 1 (15-10-2021)

Identifiers

Cite

Sophie Mouillet-Richard, Alexandre Ghazi, Pierre Laurent-Puig. The Cellular Prion Protein and the Hallmarks of Cancer. Cancers, 2021, 13 (19), pp.5032. ⟨10.3390/cancers13195032⟩. ⟨hal-03379898⟩
54 View
89 Download

Altmetric

Share

More